Cargando…

Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome

BACKGROUND: Autosomal recessive cerebellar ataxias (ARCA) are a group of rare inherited disorders characterized by degeneration or abnormal development of the cerebellum. Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is one of the most prevalent in Europe. OBJECTIVES: The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Marjolaine, Girard-Côté, Laura, Brais, Bernard, Gagnon, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526980/
https://www.ncbi.nlm.nih.gov/pubmed/36183078
http://dx.doi.org/10.1186/s13023-022-02497-1
_version_ 1784800988496920576
author Tremblay, Marjolaine
Girard-Côté, Laura
Brais, Bernard
Gagnon, Cynthia
author_facet Tremblay, Marjolaine
Girard-Côté, Laura
Brais, Bernard
Gagnon, Cynthia
author_sort Tremblay, Marjolaine
collection PubMed
description BACKGROUND: Autosomal recessive cerebellar ataxias (ARCA) are a group of rare inherited disorders characterized by degeneration or abnormal development of the cerebellum. Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is one of the most prevalent in Europe. OBJECTIVES: The aim of this study is to provide a better understanding of the manifestations and impacts of ARSACS. METHODS: A systematic review of the literature was conducted, followed by a qualitative study using semistructured interviews and discussion groups to obtain the experience of people affected. RESULTS: According to the PROMIS framework, the results show manifestations and impacts in three components of health: physical, mental, and social. Fatigue and struggles with balance and dexterity are the physical manifestations of the disease most often cited by participants. Negative affects such as frustration and depression are among the mental health impacts with some loss in cognitive abilities. Social health is the least documented component; nonetheless, people with the disease report significant impacts in terms of social relationships, activities and work. CONCLUSIONS: These findings shed new light on the experience of people with recessive ataxia and identify key aspects to assess to improve their overall health.
format Online
Article
Text
id pubmed-9526980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95269802022-10-03 Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome Tremblay, Marjolaine Girard-Côté, Laura Brais, Bernard Gagnon, Cynthia Orphanet J Rare Dis Research BACKGROUND: Autosomal recessive cerebellar ataxias (ARCA) are a group of rare inherited disorders characterized by degeneration or abnormal development of the cerebellum. Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is one of the most prevalent in Europe. OBJECTIVES: The aim of this study is to provide a better understanding of the manifestations and impacts of ARSACS. METHODS: A systematic review of the literature was conducted, followed by a qualitative study using semistructured interviews and discussion groups to obtain the experience of people affected. RESULTS: According to the PROMIS framework, the results show manifestations and impacts in three components of health: physical, mental, and social. Fatigue and struggles with balance and dexterity are the physical manifestations of the disease most often cited by participants. Negative affects such as frustration and depression are among the mental health impacts with some loss in cognitive abilities. Social health is the least documented component; nonetheless, people with the disease report significant impacts in terms of social relationships, activities and work. CONCLUSIONS: These findings shed new light on the experience of people with recessive ataxia and identify key aspects to assess to improve their overall health. BioMed Central 2022-10-01 /pmc/articles/PMC9526980/ /pubmed/36183078 http://dx.doi.org/10.1186/s13023-022-02497-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tremblay, Marjolaine
Girard-Côté, Laura
Brais, Bernard
Gagnon, Cynthia
Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title_full Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title_fullStr Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title_full_unstemmed Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title_short Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix–Saguenay to develop patient-reported outcome
title_sort documenting manifestations and impacts of autosomal recessive spastic ataxia of charlevoix–saguenay to develop patient-reported outcome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526980/
https://www.ncbi.nlm.nih.gov/pubmed/36183078
http://dx.doi.org/10.1186/s13023-022-02497-1
work_keys_str_mv AT tremblaymarjolaine documentingmanifestationsandimpactsofautosomalrecessivespasticataxiaofcharlevoixsaguenaytodeveloppatientreportedoutcome
AT girardcotelaura documentingmanifestationsandimpactsofautosomalrecessivespasticataxiaofcharlevoixsaguenaytodeveloppatientreportedoutcome
AT braisbernard documentingmanifestationsandimpactsofautosomalrecessivespasticataxiaofcharlevoixsaguenaytodeveloppatientreportedoutcome
AT gagnoncynthia documentingmanifestationsandimpactsofautosomalrecessivespasticataxiaofcharlevoixsaguenaytodeveloppatientreportedoutcome